US President Donald Trump is to nominate Stephen Hahn, a radiation oncologist, as the next commissioner of the Food and Drug Administration, CNN reports.
Hahn is currently the chief medical executive of the University of Texas MD Anderson Cancer Center and prior to that was the chair of radiation oncology at the University of Pennsylvania School of Medicine, CNN adds. It notes that he has a reputation at MD Anderson for "turning its budget around" following financial losses in 2016.
According to Politico, Hahn was also being wooed by Memorial Sloan Kettering Cancer Center and administration officials sought to lure him away, viewing him as someone who would be a relatively easy confirmation sell, as compared to the current acting FDA commissioner Norman Sharpless.
Sharpless took over the helm of the FDA when the prior commissioner, Scott Gottlieb, stepped down earlier this year. As Politico notes, Sharpless has had the support of cancer researchers and patient advocacy groups, but has had trouble gaining lawmakers' support, particularly for the agency's approach to combat vaping by teenagers. He is instead to return to NCI, according to an announcement from Health and Human Services Secretary Alex Azar.